AR and prostate cancer: Treatment with AU-15330 induced selective proteolysis of the core subunits (SMARCA2 and SMARCA4) and promoted the dislodging of AR and FOXA1 from chromatin in prostate cancer cell lines and suppressed the growth of xenograft prostatic tumors in mice.